Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Cardiotoxicity 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma 3Sarcoma 2Leukemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1PRETEXT I Hepatoblastoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Lymphoma, Large B-Cell, Diffuse 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Inflammatory Breast Neoplasms 1Heart Failure 1Ganglioneuroblastoma 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

Vincristine 1Topotecan 1Razoxane 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Localized Extraskeletal Ewing Sarcoma × Dexrazoxane × Clear all
NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed
642 enrolled 11 charts
Sarcoma

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡